Aprecia
Rob Williford is a seasoned executive in the pharmaceutical industry, currently serving as Chief Operating Officer at Aprecia Pharmaceuticals. With a comprehensive background that includes leadership roles as General Manager at Teva Pharmaceuticals from 2008 to 2011 and Barr Laboratories from 2001 to 2008, Rob also held the position of Vice President at Duramed Pharmaceuticals from 1998 to 2001. Rob's academic credentials include a degree from Brown University, where studies were undertaken from 1981 to 1985.
This person is not in the org chart
This person is not in any teams
Aprecia
2 followers
Aprecia is the global leader in 3DP pharmaceutical manufacturing and the world’s first and only FDA-validated, commercial scale technology for 3D printing in medicine.